# Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

> **NCT00252291** · PHASE3 · COMPLETED · sponsor: **Syntara** · enrollment: 240 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Aridol
- **DRUG:** Methacholine
- **PROCEDURE:** Exercise challenge

## Key facts

- **NCT ID:** NCT00252291
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 240 (—)
- **Last updated:** 2009-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252291, "Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00252291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*